These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39193344)
1. Phosphoenolpyruvate carboxykinase 2-mediated metabolism promotes lung tumorigenesis by inhibiting mitochondrial-associated apoptotic cell death. Zhang J; He W; Liu D; Zhang W; Qin H; Zhang S; Cheng A; Li Q; Wang F Front Pharmacol; 2024; 15():1434988. PubMed ID: 39193344 [TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma. Liu MX; Jin L; Sun SJ; Liu P; Feng X; Cheng ZL; Liu WR; Guan KL; Shi YH; Yuan HX; Xiong Y Oncogene; 2018 Mar; 37(12):1637-1653. PubMed ID: 29335519 [TBL] [Abstract][Full Text] [Related]
5. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Leithner K; Hrzenjak A; Trötzmüller M; Moustafa T; Köfeler HC; Wohlkoenig C; Stacher E; Lindenmann J; Harris AL; Olschewski A; Olschewski H Oncogene; 2015 Feb; 34(8):1044-50. PubMed ID: 24632615 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway. Hsu HP; Chu PY; Chang TM; Huang KW; Hung WC; Jiang SS; Lin HY; Tsai HJ Cancer Med; 2023 Jan; 12(2):1588-1601. PubMed ID: 35757841 [TBL] [Abstract][Full Text] [Related]
7. Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer. Smolle E; Leko P; Stacher-Priehse E; Brcic L; El-Heliebi A; Hofmann L; Quehenberger F; Hrzenjak A; Popper HH; Olschewski H; Leithner K Mol Oncol; 2020 Nov; 14(11):2853-2867. PubMed ID: 32777161 [TBL] [Abstract][Full Text] [Related]
8. PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells. Bluemel G; Planque M; Madreiter-Sokolowski CT; Haitzmann T; Hrzenjak A; Graier WF; Fendt SM; Olschewski H; Leithner K Free Radic Biol Med; 2021 Nov; 176():34-45. PubMed ID: 34520823 [TBL] [Abstract][Full Text] [Related]
9. PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner. Hyroššová P; Aragó M; Moreno-Felici J; Fu X; Mendez-Lucas A; García-Rovés PM; Burgess S; Figueras A; Viñals F; Perales JC Cancer Metab; 2021 Jan; 9(1):1. PubMed ID: 33413684 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial phosphoenolpyruvate carboxykinase inhibits kidney renal clear cell carcinoma malignant progression, leading to cell energy metabolism imbalance. Chen Y; Wang Z; Deng Q; Chen Y; Liang H Am J Cancer Res; 2023; 13(3):886-899. PubMed ID: 37034209 [TBL] [Abstract][Full Text] [Related]
11. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma. Li C; Zhang ED; Ye Y; Xiao Z; Huang H; Zeng Z Sci Rep; 2024 Jun; 14(1):14051. PubMed ID: 38890507 [TBL] [Abstract][Full Text] [Related]
12. Biallelic pathogenic variants in the mitochondrial form of phosphoenolpyruvate carboxykinase cause peripheral neuropathy. Sondheimer N; Aleman A; Cameron J; Gonorazky H; Sabha N; Oliveira P; Amburgey K; Wahedi A; Wang D; Shy M; Dowling JJ HGG Adv; 2023 Apr; 4(2):100182. PubMed ID: 36845668 [TBL] [Abstract][Full Text] [Related]
13. Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism. Chen Z; Tang WJ; Zhou YH; Chen ZM; Liu K Ann Transl Med; 2021 Nov; 9(22):1701. PubMed ID: 34988210 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. Xue S; Cai Y; Liu J; Ji K; Yi P; Long H; Zhang X; Li P; Song Y Cell Signal; 2024 Aug; 120():111198. PubMed ID: 38697449 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors. Chu PY; Jiang SS; Shan YS; Hung WC; Chen MH; Lin HY; Chen YL; Tsai HJ; Chen LT Oncotarget; 2017 Nov; 8(61):103613-103625. PubMed ID: 29262588 [TBL] [Abstract][Full Text] [Related]
16. Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis. Yu S; Meng S; Xiang M; Ma H Mol Metab; 2021 Nov; 53():101257. PubMed ID: 34020084 [TBL] [Abstract][Full Text] [Related]
17. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells. Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212 [TBL] [Abstract][Full Text] [Related]
18. The LncRNA FEZF1-AS1 promotes tumor proliferation in colon cancer by regulating the mitochondrial protein PCK2. Wang H; Wu Y; Wang Z; Chen Y; Mo J; Guan W; Zhang Y; Yao H Oncol Res; 2021; 29(3):201-215. PubMed ID: 37304670 [TBL] [Abstract][Full Text] [Related]
19. Tang M; Sun J; Cai Z J Thorac Dis; 2023 May; 15(5):2601-2615. PubMed ID: 37324064 [TBL] [Abstract][Full Text] [Related]
20. The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells. Leithner K; Triebl A; Trötzmüller M; Hinteregger B; Leko P; Wieser BI; Grasmann G; Bertsch AL; Züllig T; Stacher E; Valli A; Prassl R; Olschewski A; Harris AL; Köfeler HC; Olschewski H; Hrzenjak A Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6225-6230. PubMed ID: 29844165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]